Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.

Ramos CA, Rouce R, Robertson CS, Reyna A, Narala N, Vyas G, Mehta B, Zhang H, Dakhova O, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Savoldo B, Dotti G.

Mol Ther. 2018 Dec 5;26(12):2727-2737. doi: 10.1016/j.ymthe.2018.09.009. Epub 2018 Sep 13.

2.

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation.

McLaughlin LP, Rouce R, Gottschalk S, Torrano V, Carrum G, Wu MF, Hoq F, Grilley B, Marcogliese AM, Hanley PJ, Gee AP, Brenner MK, Rooney CM, Heslop HE, Bollard CM.

Blood. 2018 Nov 29;132(22):2351-2361. doi: 10.1182/blood-2018-07-863654. Epub 2018 Sep 27.

3.

Efficacy of Afternoon Plerixafor Administration for Stem Cell Mobilization.

El Rahi C, Cox JE, May R, Carrum G, Anyadike GO, Scholoff A, Kamble R.

Clin Med Insights Blood Disord. 2018 Aug 30;11:1179545X18792253. doi: 10.1177/1179545X18792253. eCollection 2018.

4.

Voriconazole photosensitivity causes apparent graft-versus-host disease exacerbation.

Mukherjee A, Ekinci E, Scholoff A, Obi G, Vu N, Carrum G, Kamble RT.

Bone Marrow Transplant. 2019 Feb;54(2):323-325. doi: 10.1038/s41409-018-0285-3. Epub 2018 Aug 7. No abstract available.

PMID:
30087464
5.

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease.

Yanir AD, Hanson IC, Shearer WT, Noroski LM, Forbes LR, Seeborg FO, Nicholas S, Chinn I, Orange JS, Rider NL, Leung KS, Naik S, Carrum G, Sasa G, Hegde M, Omer BA, Ahmed N, Allen CE, Khaled Y, Wu MF, Liu H, Gottschalk SM, Heslop HE, Brenner MK, Krance RA, Martinez CA.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1643-1650. doi: 10.1016/j.bbmt.2018.03.029. Epub 2018 Apr 6.

6.

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.

Bollard CM, Tripic T, Cruz CR, Dotti G, Gottschalk S, Torrano V, Dakhova O, Carrum G, Ramos CA, Liu H, Wu MF, Marcogliese AN, Barese C, Zu Y, Lee DY, O'Connor O, Gee AP, Brenner MK, Heslop HE, Rooney CM.

J Clin Oncol. 2018 Apr 10;36(11):1128-1139. doi: 10.1200/JCO.2017.74.3179. Epub 2018 Jan 9.

7.

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation.

Tzannou I, Papadopoulou A, Naik S, Leung K, Martinez CA, Ramos CA, Carrum G, Sasa G, Lulla P, Watanabe A, Kuvalekar M, Gee AP, Wu MF, Liu H, Grilley BJ, Krance RA, Gottschalk S, Brenner MK, Rooney CM, Heslop HE, Leen AM, Omer B.

J Clin Oncol. 2017 Nov 1;35(31):3547-3557. doi: 10.1200/JCO.2017.73.0655. Epub 2017 Aug 7.

8.

Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.

Kapke JT, Epperla N, Shah N, Richardson K, Carrum G, Hari PN, Pingali SR, Hamadani M, Karmali R, Fenske TS.

Clin Lymphoma Myeloma Leuk. 2017 Jul;17(7):408-414. doi: 10.1016/j.clml.2017.05.005. Epub 2017 May 12.

PMID:
28756899
9.

Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation.

Epperla N, Shah N, Hamadani M, Richardson K, Kapke JT, Patel A, Teegavarapu SP, Carrum G, Hari PN, Pingali SR, Karmali R, Fenske TS.

Clin Lymphoma Myeloma Leuk. 2016 Dec;16(12):672-678. doi: 10.1016/j.clml.2016.08.018. Epub 2016 Aug 29.

PMID:
27660080
10.

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains.

Ramos CA, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, Liu E, Carrum G, Kamble RT, Gee AP, Mei Z, Wu MF, Liu H, Grilley B, Rooney CM, Brenner MK, Heslop HE, Dotti G.

J Clin Invest. 2016 Jul 1;126(7):2588-96. doi: 10.1172/JCI86000. Epub 2016 Jun 6.

11.

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

Papadopoulou A, Gerdemann U, Katari UL, Tzannou I, Liu H, Martinez C, Leung K, Carrum G, Gee AP, Vera JF, Krance RA, Brenner MK, Rooney CM, Heslop HE, Leen AM.

Sci Transl Med. 2014 Jun 25;6(242):242ra83. doi: 10.1126/scitranslmed.3008825.

12.

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD.

Kamble RT, Scholoff A, Obi AG, Heslop HE, Brenner MK, Carrum G.

Bone Marrow Transplant. 2014 Jul;49(7):986-7. doi: 10.1038/bmt.2014.77. Epub 2014 Apr 28. No abstract available.

PMID:
24777189
13.

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

Kennedy-Nasser AA, Ku S, Castillo-Caro P, Hazrat Y, Wu MF, Liu H, Melenhorst J, Barrett AJ, Ito S, Foster A, Savoldo B, Yvon E, Carrum G, Ramos CA, Krance RA, Leung K, Heslop HE, Brenner MK, Bollard CM.

Clin Cancer Res. 2014 Apr 15;20(8):2215-25. doi: 10.1158/1078-0432.CCR-13-3205. Epub 2014 Feb 26.

14.

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.

Bollard CM, Gottschalk S, Torrano V, Diouf O, Ku S, Hazrat Y, Carrum G, Ramos C, Fayad L, Shpall EJ, Pro B, Liu H, Wu MF, Lee D, Sheehan AM, Zu Y, Gee AP, Brenner MK, Heslop HE, Rooney CM.

J Clin Oncol. 2014 Mar 10;32(8):798-808. doi: 10.1200/JCO.2013.51.5304. Epub 2013 Dec 16.

15.

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.

Cox JE, Campos S, Wu J, May R, Liu H, Ramos CA, Carrum G, Heslop HE, Brenner MK, Kamble RT.

Bone Marrow Transplant. 2014 Feb;49(2):219-22. doi: 10.1038/bmt.2013.149. Epub 2013 Oct 7.

16.

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.

Cruz CR, Micklethwaite KP, Savoldo B, Ramos CA, Lam S, Ku S, Diouf O, Liu E, Barrett AJ, Ito S, Shpall EJ, Krance RA, Kamble RT, Carrum G, Hosing CM, Gee AP, Mei Z, Grilley BJ, Heslop HE, Rooney CM, Brenner MK, Bollard CM, Dotti G.

Blood. 2013 Oct 24;122(17):2965-73. doi: 10.1182/blood-2013-06-506741. Epub 2013 Sep 12. Erratum in: Blood. 2014 May 22;123(21):3364.

17.

Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.

Chen J, Burns KM, Babic A, Carrum G, Kennedy M, Segura FJ, Garcia S, Potts S, Leveque C.

Transfusion. 2014 Jan;54(1):203-10. doi: 10.1111/trf.12238. Epub 2013 Jun 13.

PMID:
23763340
18.

Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone.

Sung AD, Grima DT, Bernard LM, Brown S, Carrum G, Holmberg L, Horwitz ME, Liesveld JL, Kanda J, McClune B, Shaughnessy P, Tricot GJ, Chao NJ.

Bone Marrow Transplant. 2013 Nov;48(11):1444-9. doi: 10.1038/bmt.2013.80. Epub 2013 Jun 10.

19.

Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

Pasquini MC, Voltarelli J, Atkins HL, Hamerschlak N, Zhong X, Ahn KW, Sullivan KM, Carrum G, Andrey J, Bredeson CN, Cairo M, Gale RP, Hahn T, Storek J, Horowitz MM, McSweeney PA, Griffith LM, Muraro PA, Pavletic SZ, Nash RA.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1471-8. doi: 10.1016/j.bbmt.2012.06.003. Epub 2012 Jun 13.

20.

Systemic effects of oral budesonide in hematopoietic transplant: implications of drug interaction with azoles.

El Fakih R, Obi GA, Scholoff A, Carrum G, Kamble RT.

Bone Marrow Transplant. 2012 Oct;47(10):1370-1. doi: 10.1038/bmt.2012.17. Epub 2012 Feb 13. No abstract available.

PMID:
22327133
21.

Acute gout at engraftment following hematopoietic transplantation.

Kamble RT, Guo S, Ramos CA, Carrum G.

Am J Hematol. 2011 Nov;86(11):961-2. doi: 10.1002/ajh.22149. Epub 2011 Sep 21. No abstract available.

22.

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia.

Okur FV, Yvon E, Biagi E, Dotti G, Carrum G, Heslop H, Mims MP, Fratantoni JC, Peshwa MV, Li L, Brenner MK.

Cytotherapy. 2011 Oct;13(9):1128-39. doi: 10.3109/14653249.2011.592523. Epub 2011 Jul 12.

23.

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.

Savoldo B, Ramos CA, Liu E, Mims MP, Keating MJ, Carrum G, Kamble RT, Bollard CM, Gee AP, Mei Z, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Dotti G.

J Clin Invest. 2011 May;121(5):1822-6. doi: 10.1172/JCI46110. Epub 2011 Apr 11.

24.

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.

Samuelson S, Sandmaier BM, Heslop HE, Popat U, Carrum G, Champlin RE, Storb R, Prchal JT, Gooley TA, Deeg HJ.

Br J Haematol. 2011 Apr;153(1):76-82. doi: 10.1111/j.1365-2141.2011.08582.x. Epub 2011 Feb 17.

25.

Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution.

Shafer JA, Heslop HE, Brenner MK, Carrum G, Wu MF, Liu H, Ahmed N, Gottschalk S, Kamble R, Leung KS, Myers GD, Bollard CM, Krance RA.

Leuk Lymphoma. 2010 Apr;51(4):664-70. doi: 10.3109/10428190903580410.

26.

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine.

Foster AE, Okur FV, Biagi E, Lu A, Dotti G, Yvon E, Savoldo B, Carrum G, Goodell MA, Heslop HE, Brenner MK.

Leukemia. 2010 Mar;24(3):563-72. doi: 10.1038/leu.2009.281. Epub 2010 Jan 14.

27.

Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression.

Foster AE, Okur FV, Biagi E, Lu A, Dotti G, Yvon E, Savoldo B, Carrum G, Andreeff M, Goodell MA, Heslop HE, Brenner MK.

Mol Cancer. 2009 Nov 18;8:106. doi: 10.1186/1476-4598-8-106.

28.
29.

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.

Ahmed N, Leung KS, Rosenblatt H, Bollard CM, Gottschalk S, Myers GD, Carrum G, Heslop HE, Brenner MK, Krance RA.

Biol Blood Marrow Transplant. 2008 Nov;14(11):1298-304. doi: 10.1016/j.bbmt.2008.09.003.

30.

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis.

Appel SH, Engelhardt JI, Henkel JS, Siklos L, Beers DR, Yen AA, Simpson EP, Luo Y, Carrum G, Heslop HE, Brenner MK, Popat U.

Neurology. 2008 Oct 21;71(17):1326-34. doi: 10.1212/01.wnl.0000327668.43541.22.

PMID:
18936424
31.

Human metapneumovirus infection in a hematopoietic transplant recipient.

Kamble RT, Bollard C, Demmler G, LaSala PR, Carrum G.

Bone Marrow Transplant. 2007 Oct;40(7):699-700. Epub 2007 Jul 30. No abstract available.

PMID:
17660843
32.

Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation.

Kamble RT, Clark DA, Leong HN, Heslop HE, Brenner MK, Carrum G.

Bone Marrow Transplant. 2007 Sep;40(6):563-6. Epub 2007 Jul 16.

PMID:
17637686
33.

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

Bollard CM, Gottschalk S, Leen AM, Weiss H, Straathof KC, Carrum G, Khalil M, Wu MF, Huls MH, Chang CC, Gresik MV, Gee AP, Brenner MK, Rooney CM, Heslop HE.

Blood. 2007 Oct 15;110(8):2838-45. Epub 2007 Jul 3.

34.

Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation.

Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R.

Bone Marrow Transplant. 2007 Jun;39(11):705-9. Epub 2007 Apr 2.

PMID:
17401392
35.

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.

Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S, Carrum G, Khan SP, Heslop HE, Brenner MK, Bollard CM, Krance RA.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1277-84.

36.

Central nervous system graft-versus-host disease: report of two cases and literature review.

Kamble RT, Chang CC, Sanchez S, Carrum G.

Bone Marrow Transplant. 2007 Jan;39(1):49-52. Epub 2006 Nov 13.

PMID:
17099715
37.

Rituximab responsive refractory acute graft-versus-host disease.

Kamble R, Oholendt M, Carrum G.

Biol Blood Marrow Transplant. 2006 Nov;12(11):1201-2. No abstract available.

38.

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

Leen AM, Myers GD, Sili U, Huls MH, Weiss H, Leung KS, Carrum G, Krance RA, Chang CC, Molldrem JJ, Gee AP, Brenner MK, Heslop HE, Rooney CM, Bollard CM.

Nat Med. 2006 Oct;12(10):1160-6. Epub 2006 Sep 24.

PMID:
16998485
39.

Successful mobilization and transplantation of filgrastim mobilized hematopoietic stem cells in sickle cell-hemoglobin C disease.

Kamble RT, Tin-U CK, Carrum G.

Bone Marrow Transplant. 2006 Jun;37(11):1065-6. No abstract available.

PMID:
16708064
40.

Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma.

Bollard CM, Huls MH, Buza E, Weiss H, Torrano V, Gresik MV, Chang J, Gee A, Gottschalk SM, Carrum G, Brenner MK, Rooney CM, Heslop HE.

Clin Lymphoma Myeloma. 2006 Jan;6(4):342-7. No abstract available.

PMID:
16507214
41.

Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML).

Popat U, Heslop HE, Durett A, May R, Krance RA, Brenner MK, Carrum G.

Bone Marrow Transplant. 2006 Mar;37(6):547-52.

PMID:
16462757
42.

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

Rousseau RF, Biagi E, Dutour A, Yvon ES, Brown MP, Lin T, Mei Z, Grilley B, Popek E, Heslop HE, Gee AP, Krance RA, Popat U, Carrum G, Margolin JF, Brenner MK.

Blood. 2006 Feb 15;107(4):1332-41. Epub 2005 Oct 25.

43.

Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia.

Biagi E, Rousseau R, Yvon E, Schwartz M, Dotti G, Foster A, Havlik-Cooper D, Grilley B, Gee A, Baker K, Carrum G, Rice L, Andreeff M, Popat U, Brenner M.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6916-23.

44.

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab.

Lamba R, Carrum G, Myers GD, Bollard CM, Krance RA, Heslop HE, Brenner MK, Popat U.

Bone Marrow Transplant. 2005 Nov;36(9):797-802.

PMID:
16151431
45.

CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors.

Popat U, Carrum G, May R, Lamba R, Krance RA, Heslop HE, Brenner MK.

Bone Marrow Transplant. 2005 Jun;35(12):1127-32.

PMID:
15834432
46.

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.

Bollard CM, Aguilar L, Straathof KC, Gahn B, Huls MH, Rousseau A, Sixbey J, Gresik MV, Carrum G, Hudson M, Dilloo D, Gee A, Brenner MK, Rooney CM, Heslop HE.

J Exp Med. 2004 Dec 20;200(12):1623-33.

47.

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis.

Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZ.

Brain. 2004 May;127(Pt 5):996-1008. Epub 2004 Feb 25.

PMID:
14985264
48.

Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia.

Ganguly S, Carrum G, Nizzi F, Heslop HE, Popat U.

Am J Hematol. 2004 Jan;75(1):48-51.

49.

Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia.

Popat U, Carrum G, Heslop HE.

Cancer Treat Rev. 2003 Feb;29(1):3-10. Review.

PMID:
12633575
50.

Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.

Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MM.

Leuk Lymphoma. 2002 Feb;43(2):423-6.

PMID:
11999580

Supplemental Content

Loading ...
Support Center